OptimizeRx to Present at Investor Conferences in May
2019年4月23日 - 9:31PM
OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging
platform for the pharmaceutical industry, has been invited to
present at three institutional investor conferences in May.
Event: Oppenheimer Emerging Growth ConferenceDate: May 14,
2019Location: InterContinental Barclay Hotel in NYCFormat: 1x1
meetingsRegistration: Please contact your Oppenheimer & Co.
Inc. institutional sales representative
Event: B. Riley FBR Investor ConferenceDate: May 22-23,
2019Location: The Beverly Hilton Hotel in Beverly Hills,
CaliforniaFormat: 1x1 meetings and presentationPresentation time:
1:00 p.m. Pacific timeWebcast: click hereRegistration: email
1on1@brileyfbr.com or click here
Event: Ladenburg Thalmann Technology Expo 2019 Date: May 30,
2019Location: 101 Park Avenue in NYCFormat: 1x1 meetings and
presentationPresentation time: 4:00 p.m. Eastern
timeRegistration: click here
These events are designed to give institutional analysts and
investors the opportunity to meet with OptimizeRx management.
They will be discussing a number of topics, including the company’s
record results for the fourth quarter of 2018, the acquisition of
CareSpeak Communications, and growth of the company’s digital
health platform. The network has become the largest of its kind,
now reaching more than half of the ambulatory patient market in the
U.S.
The company recently reported its seventh sequential quarter of
revenue growth, driving 2018 revenue up 75% to a record $21.2
million and the company’s first year of profitability. The company
plans to maintain a gross margin target of at least 55% in 2019, as
new digital health messaging pharma clients and programs ramp
up.
To schedule a one-on-one meeting with OptimizeRx, you may submit
your request via the links provided upon your registration for the
conferences. For any questions about the company, please contact
Ron Both of CMA at (949) 432-7557 or submit your request here.
About OptimizeRxOptimizeRx® (NASDAQ: OPRX), a
digital health company, connects pharmaceutical companies
to patients and providers, offering greater affordability,
adherence and brand awareness at the point-of-care. As the nation’s
largest point-of-prescribe promotional platform for the
pharmaceutical industry, OptimizeRx provides a direct
channel for pharma companies to communicate with healthcare
providers right within their workflow and also directly to
patients.
The cloud-based solution supports patient adherence to
medications and better healthcare outcomes with real-time access to
financial assistance, prior authorization, education and critical
clinical information. OptimizeRx provides more than half
of the ambulatory patient market with access to these benefits
through leading EHR platforms like Allscripts, Amazing Charts and
Quest, and directly via its mobile communications
platform.
For more information, follow the company
on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
Statements This press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition and other material risks.
OptimizeRx ContactDoug Baker, CFOTel (248)
651-6568 x807dbaker@optimizerx.com
Media Relations ContactNicole Brooks, Innsena
CommunicationsTel (860) 800-2344nicolebrooks@innsena.com
Investor Relations ContactRon Both, CMATel
(949) 432-7557oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
過去 株価チャート
から 6 2024 まで 7 2024
OptimizeRx (NASDAQ:OPRX)
過去 株価チャート
から 7 2023 まで 7 2024